Private Advisor Group LLC Sells 432 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Private Advisor Group LLC lowered its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 17.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,112 shares of the company’s stock after selling 432 shares during the quarter. Private Advisor Group LLC’s holdings in HealthEquity were worth $203,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in HQY. Wasatch Advisors LP grew its stake in shares of HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares during the period. Vaughan Nelson Investment Management L.P. raised its holdings in HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after acquiring an additional 226,563 shares in the last quarter. Barclays PLC raised its stake in HealthEquity by 209.3% in the third quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after buying an additional 112,667 shares during the period. Thrivent Financial for Lutherans raised its stake in HealthEquity by 33.3% in the third quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock valued at $24,033,000 after buying an additional 73,404 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of HealthEquity during the third quarter worth approximately $5,675,000. Institutional investors own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares in the company, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,000 shares of company stock worth $3,895,788. Insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on HQY shares. The Goldman Sachs Group initiated coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. Royal Bank of Canada raised their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. BTIG Research increased their price target on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. JMP Securities raised their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Finally, Bank of America lifted their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $113.54.

HealthEquity Price Performance

HQY stock opened at $101.27 on Friday. The company has a market capitalization of $8.78 billion, a P/E ratio of 92.91, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The business has a 50-day simple moving average of $105.63 and a two-hundred day simple moving average of $94.16.

HealthEquity (NASDAQ:HQY) last released its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the business earned $0.40 earnings per share. Research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.